✦ LIBER ✦

Dermatan sulfate inhibits osteoclast formation by binding to receptor activator of NF-κB ligand

✍ Scribed by Kouhei Shinmyouzu; Tetsu Takahashi; Wataru Ariyoshi; Hisashi Ichimiya; Shin Kanzaki; Tatsuji Nishihara

Book ID: 116294269
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 476 KB
Volume: 354
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2006.12.221

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of receptor activator of nucl

Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ)

✍ Erdenezaya Odkhuu; Naoki Koide; Abedul Haque; Bilegtsaikhan Tsolmongyn; Yoshikaz 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 861 KB

Profiling signalling pathways of the rec

Profiling signalling pathways of the receptor activator of NF-κB ligand-induced osteoclast formation in mouse monocyte cells, RAW264.7

✍ M. H. Kim; B. T. Kim; Y. K. Min; S. H. Kim 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 644 KB

Soluble glucocorticoid-induced tumor nec

Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) stimulates osteoclast differentiation in response to receptor activator of NF-κB ligand (RANKL) in osteoclast cells

✍ Hyun-Hee Shin; Soo-Jin Kim; Dong-Sul Lee; Hye-Seon Choi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 395 KB

Infliximab acts directly on human osteoc

Infliximab acts directly on human osteoclast precursors and enhances osteoclast formation induced by receptor activator of nuclear factor κB ligand in vitro

✍ Chikahiro Takita; Yosuke Fujikawa; Ichiro Itonaga; Hirofumi Taira; Masayuki Kawa 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 372 KB

IL-23 promotes osteoclast formation by u

IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-κB (RANK) expression in myeloid precursor cells

✍ Li Chen; Xiao-Qing Wei; Bronwen Evans; Wenguo Jiang; Daniel Aeschlimann 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB

## Abstract Inflammation‐mediated bone loss is a major feature of various bone diseases including rheumatoid arthritis, osteoarthritis and advanced periodontitis. Enhanced osteoclast development or activity at the inflammation site results in bone resorption. IL‐23 is a heterodimeric cytokine belon

New insight in the mechanism of osteocla

New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-κB ligand (RANKL)

✍ Nicola Giuliani; Simona Colla; Vittorio Rizzoli 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 306 KB